| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851434 | American Heart Journal | 2006 | 7 Pages |
Abstract
Despite routine stenting and glycoprotein IIb/IIIa inhibitor therapy, RI remains an independent predictor of increased morbidity, and particularly mortality, after PCI. However, the adverse effect of truly mild RI on outcome is limited.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Daniel J. MD, Ruxandra PhD, John R. MD, Peter H. MD, Douglas MD, Cynthia DPharm, Karen RN, Christopher MD, Vladimir MD,